secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cabaletta Bio, Inc. (CABA)
CIK:        0001759138
Form:       8-K
Filed at:   2025-06-10T23:59:59+00:00
Accession:  0001193125-25-137954
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cabaletta Bio stockholders approve doubling authorized common shares to 300M, elect directors at annual meeting
--------------------------------------------------------------------------------

- Authorized shares increased from 150M to 300M; approved by 32.6M for vs 2.0M against.
- Steven Nichtberger, M.D. and Mark Simon, MBA re-elected as Class III directors through 2028.
- Ernst & Young LLP ratified as independent auditor for fiscal year ending Dec 31, 2025.
- Say-on-pay approved with 52% support; stockholders selected annual frequency for future advisory votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759138/000119312525137954/0001193125-25-137954-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759138/000119312525137954/d46354d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-137954

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer